Parkman-Healthcare-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
91
Total Value
843125283
Accession Number
0001420506-25-001258
Form Type
13F-HR
Manager Name
Parkman-Healthcare-Partners
Data Enrichment
97% identified
88 identified3 unidentified

Holdings

91 positions • $843.1M total value
Manager:
Search and click to pin securities to the top
Page 5 of 5
Upstream Bio, Inc.
Shares:233.6K
Value:$1.4M
% of Portfolio:0.2% ($1.4M/$843.1M)
Merus N.V.
Shares:28.2K
Value:$1.2M
% of Portfolio:0.1% ($1.2M/$843.1M)
Silence Therapeutics plc
Shares:401.7K
Value:$1.1M
% of Portfolio:0.1% ($1.1M/$843.1M)
Oric Pharmaceuticals, Inc.
Shares:203.0K
Value:$1.1M
% of Portfolio:0.1% ($1.1M/$843.1M)
ARDELYX, INC.
Shares:209.6K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$843.1M)
Entera Bio Ltd.
Shares:439.6K
Value:$747.4K
% of Portfolio:0.1% ($747.4K/$843.1M)
Annexon, Inc.
Shares:351.4K
Value:$678.3K
% of Portfolio:0.1% ($678.3K/$843.1M)
Relay Therapeutics, Inc.
Shares:188.1K
Value:$492.7K
% of Portfolio:0.1% ($492.7K/$843.1M)
VYNE Therapeutics Inc.
Shares:218.0K
Value:$344.4K
% of Portfolio:0.0% ($344.4K/$843.1M)
EDAP TMS SA
Shares:154.8K
Value:$303.5K
% of Portfolio:0.0% ($303.5K/$843.1M)
IRONWOOD PHARMACEUTICALS INC
Shares:205.1K
Value:$301.5K
% of Portfolio:0.0% ($301.5K/$843.1M)